Latest Blog Posts Tagged "Subcutaneous"
November 04, 2014
Researchers shared updates on the current research in understanding Parkinson's and developing new drugs at the annual Parkinson's Disease Therapeutics Conference.
July 31, 2014
The Austrian biotech AFFiRiS AG announced positive results of its Phase I safety trial of a vaccine against alpha-synuclein, a treatment that could slow or stop Parkinson's disease .
November 21, 2013
Unpredictable on/off periods can greatly interfere with daily life, and are perhaps the major concern for today's patients. That's why MJFF is hard at work to improve existing treatments.
March 04, 2013
Israel-based biotech Neuroderm today announced positive results from a phase 1 safety and tolerability study into a levodopa/carbidopa "pump-patch" designed to continuously deliver both drugs subcutan